Ultrasound biomicroscopy is the most successful in measuring sulcus diameter

Article

Ciliary sulcus-to-sulcus (STS) diameter is most accurately measured using ultrasound biomicroscopy (UBM).

Ciliary sulcus-to-sulcus (STS) diameter is most accurately measured using ultrasound biomicroscopy (UBM), according to a paper published in the Journal of Cataract and Refractive Surgery.

The study, led by Dr Julia Biermann, University Eye Hospital Freiberg im Breisgau, Germany, measured the STS diameter at 0, 45, 90 and 135 degrees using 35 MHz UBM. The Orbscan scanning-slit topography and the partial coherence interferometry (PCI) biometry (IOLMaster) were used to obtain the 0-degree automated horizontal white-to-white (WTW) diameter.

The 90˚ STS and the 0˚ STS were compared using the paired t test and the Pearson correlation was used to determine whether the 0˚ STS diameter could be predicted from the 0˚ WTW diameter.

In emmetropic and myopic eyes the mean SE refraction was −0.48 D ± 0.35 SD and −9.55 ± 3.70 D, respectively.

The 90˚ STS was greater than 0˚ STS in 35 of the 37 eyes studied. The mean 90˚ STS and 0˚ STS were 12.51 ± 0.43 mm and 12.19 ± 0.47 mm, respectively. The mean scanning-slit topography of 0˚ WTW diameters were 11.73 ± 0.37 mm and for the PCI biometry they were 12.20 ± 0.42 mm.

A strong correlation was found between 0˚ STS and 0˚ WTW with PCI biometry and scanning-slit topography in emmetropic eyes. However, the correlation was weaker in myopic eyes.

Overall, UBM is the most accurate way to measure sulcus diameter measurements. The study also suggests that WTW diameter is not suitable for determining a posterior chamber phakic intraocular lens (PC pIOL) diameter- especially in myopic eyes.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.